- Court case puts patient privacy in peril (ama-assn.org)
What happens to physician-patient confidentiality when any government agency can obtain a patient’s prescription records without a warrant? A case before a state supreme court threatens to keep these indiscriminant lines of investigation wide open…Lewis v. Superior Court of Los Angeles County, a case before the Supreme Court of the State of California, calls into question whether or not the California Medical Board infringed upon patients’ constitutional right to privacy when it obtained prescription data without a showing of good cause. The board did so through the California Department of Justice database, which allows broad and indiscriminate disclosures to state, local and federal agencies—including law enforcement—and fails to adequately protect patient privacy.
- Reno’s hospitals growing with community (nnbw.com)
Reno’s two largest hospitals are gearing up to meet the medical needs of an expected population surge. In September, Renown announced a nearly $64 million investment that includes state-of-the-art technology, enlarging its Institute for Cancer building, creating an intermediate level of care between emergency medicine and hospital admission, and exploring the construction of a completely new medical center. Saint Mary’s Medical Group has invested $50 million in the past 18 months on new facilities and equipment, including the recently expanded medical clinic in northwest Reno, which opened Nov. 1. It has additional clinics and specialty facilities opening in other areas of the…(sub. req.)
- As competition wanes, prices for generics skyrocket (bostonglobe.com)
Concerns about the soaring prices of prescription drugs have focused on new specialty treatments that can cost tens, even hundreds of thousands of dollars per patient. But insurers, health care providers, and industry specialists are now raising alarms about a new source of rising prices: generic drugs…Insurers say they are seeing huge cost increases for some commonly used generic drugs, with prices surging 15, 25, and even 75 times what they were just two years ago…In sheer dollars, the drugs remain cheap and the increases appear modest…Several factors contribute to rising drug costs. Generic drug companies say they sometimes raise prices to offset increasing costs, such as purchasing chemicals and other raw materials. Some drug makers say they hike prices when their competitors do…Industry analysts say rising drug prices are also a result of declining market competition, which can occur when companies stop making drugs or when drug makers merge and consolidate.
- IMO warns on dangers of allowing pharmacists to take on the role of doctors (imo.ie)
“Pharmacy is first and foremost a commercial enterprise and allowing pharmacists powers to prescribe and treat patients will lead to serious conflicts of interest.”…The President of the Irish Medical Organisation has issued a strong warning of the risks that will arise for patient health and safety if pharmacists are given permission to expand their role into areas which are more properly undertaken by doctors. Due to economic reasons pharmacists are seeking to expand their professional roles and move their scope of practice into the treatment and management of patients thus undermining the role of doctors and the patient/doctor relationship. Dr. Ray Walley said that the IMO (Irish Medical Organisation) will strongly oppose attempts to allow pharmacists increase their roles in respect of activities like managing repeat prescriptions, diagnosing minor ailments, Chronic Disease Management and any further expansion of vaccination programmes.
- Walgreens on Las Vegas Strip draws eight-figure sales price (staradvertiser.com)
...this Walgreens isn't your usual neighborhood pharmacy…Then again, it's not in a typical neighborhood. It's on the Strip, and investors have again paid big money for the building in America's gambling and party mecca…The 1.6-acre property, on Las Vegas Boulevard at Convention Center Drive, sold for $37 million on Friday, up 33 percent from what the sellers paid in 2012.
- Interview: Nevada Ranks 50th For Psychiatrists Per Capita (kunr.org)
Nevada has been facing healthcare workforce shortages for decades because of the state's rapidly growing population and expanding economy. Right now...the problem is felt both in rural and urban areas across most medical specialties..."I think the ones that trouble me the most are those that we're experiencing in primary care and behavioral health, such as psychiatrists,"...Nevada ranks 50th for the state's number of psychiatrists per capita, and the state is also struggling to have enough marriage and family therapists, alcohol and drug counselors, and clinical social workers. (podcast 4:14min)
- Express Scripts cuts off pharmacy that sells drugs for Horizon Pharma (pharmalot.com)
...latest fallout over the role that specialty pharmacies play in boosting prescription drug sales, Express Scripts has ended a contract with a company that is used by Horizon Pharma to distribute some of its medicines…Express Scripts cancelled its contract with Linden Care after determining the mail-order pharmacy was apparently dispensing drugs that are mostly made by Horizon, according to a spokesman. Express Scripts, which is the nation’s largest pharmacy benefits manager, is scrutinizing what it calls captive pharmacies. Those captive pharmacies appear to sell products for mostly one drug maker…In response, Linden filed a lawsuit accusing Express Scripts of making “a trumped-up charge that Linden Care is mailing drugs out of state purportedly in violation of [its] contract.” The pharmacy also maintains Express Scripts failed to provide adequate notice that the contract was ended. Express Scripts sent its termination notice yesterday, Nov. 10.
- Renown welcomes overseas medical students (nnbw.com)
Starting next year, Renown will welcome students with St. George’s University to Reno for four- to eight-week elective clinical rotations as part of their fourth and final year of training…SGU is an independent, international school of medicine in Grenada…The students, who have already completed two years of classroom and lab studies and one year of clinical rotations elsewhere in the U.S., will receive hands-on training overseen by physicians. Renown will also welcome third year medical students from SGU, but the start date for that program expansion hasn’t been announced.
- U.S. Targets Pharmacies Over Soaring Claims to Military Health Program (wsj.com)
Settlements sought for prescriptions written in cases where doctors never met patients…Federal prosecutors in at least four states are mounting investigations into what they describe as widespread fraud by compounding pharmacies in claims to the health-insurance program that covers 9.5 million U.S. military members and their families…In the latest move, four Florida pharmacies last month agreed to pay $12.8 million combined to settle civil allegations that they falsely billed the insurance program Tricare for expensive pharmaceutical creams and gels to treat pain, scars and other ailments…Two of the compounding pharmacies...employed salespeople who paid doctors to write prescriptions to Tricare beneficiaries…In some cases, doctors would conduct telephone consultations with beneficiaries and then write them prescriptions, despite having not met with the beneficiaries in person…Those prescriptions were illegitimate because they weren’t based on genuine doctor-patient relationships, a violation of the federal False Claims Act...
- Drug industry bemoans Britain’s lack of science skills (reuters.com)Bridging the skills gap in the biopharmaceutical industry (abpi.org.uk)
British pharmaceutical and biotechnology companies face a major skills shortage which threatens future investment and the long-term success of the life sciences sector, according to a new industry report…Association of the British Pharmaceutical Industry said…that firms could increasingly seek workers abroad due to low numbers of good quality candidates, particularly those with appropriate biology and maths skills…The report follows a warning this week from lawmakers on the House of Commons science and technology committee that Britain's position as a "science superpower" would be jeopardized if government spending on science was not protected.








